These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 15142389)

  • 21. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
    ; March J; Silva S; Curry J; Wells K; Fairbank J; Burns B; Domino M; Vitiello B; Severe J; Riedal K; Goldman M; Feeny N; Findling R; Stull S; Baab S; Weller EB; Robbins M; Weller RA; Jessani N; Waslick B; Sweeney M; Dublin R; Walkup J; Ginsburg G; Kastelic E; Koo H; Kratochvil C; May D; LaGrone R; Vaughan B; Albano AM; Hirsch GS; Podniesinki E; Chu A; Reincecke M; Leventhal B; Rogers G; Jacobs R; Pathak S; Wells J; Lavanier SA; Danielyan A; Rohde P; Simons A; Grimm J; Frank S; Emslie G; Kennard B; Hughes C; Mayes TL; Rosenberg D; Benazon N; Butkus M; Bartoi M
    Am J Psychiatry; 2009 Oct; 166(10):1141-9. PubMed ID: 19723787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary report: double-blind, placebo-controlled study of fluoxetine in depressed alcoholics.
    Cornelius JR; Salloum IM; Cornelius MD; Perel JM; Ehler JG; Jarrett PJ; Levin RL; Black A; Mann JJ
    Psychopharmacol Bull; 1995; 31(2):297-303. PubMed ID: 7491382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onset of alcohol or substance use disorders following treatment for adolescent depression.
    Curry J; Silva S; Rohde P; Ginsburg G; Kennard B; Kratochvil C; Simons A; Kirchner J; May D; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
    J Consult Clin Psychol; 2012 Apr; 80(2):299-312. PubMed ID: 22250853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.
    Schmitz JM; Averill P; Stotts AL; Moeller FG; Rhoades HM; Grabowski J
    Drug Alcohol Depend; 2001 Aug; 63(3):207-14. PubMed ID: 11418225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine in child and adolescent depression: acute and maintenance treatment.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Carmody T; Mayes TL
    Depress Anxiety; 1998; 7(1):32-9. PubMed ID: 9592630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
    Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
    Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
    Papakostas GI; McGrath P; Stewart J; Charles D; Chen Y; Mischoulon D; Dording C; Fava M
    Psychiatry Res; 2008 Oct; 161(1):116-20. PubMed ID: 18755514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery and recurrence following treatment for adolescent major depression.
    Curry J; Silva S; Rohde P; Ginsburg G; Kratochvil C; Simons A; Kirchner J; May D; Kennard B; Mayes T; Feeny N; Albano AM; Lavanier S; Reinecke M; Jacobs R; Becker-Weidman E; Weller E; Emslie G; Walkup J; Kastelic E; Burns B; Wells K; March J
    Arch Gen Psychiatry; 2011 Mar; 68(3):263-9. PubMed ID: 21041606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoxetine--do the benefits outweigh the risks in adolescent major depression?
    Doggrell SA
    Expert Opin Pharmacother; 2005 Jan; 6(1):147-50. PubMed ID: 15709892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LONGER-TERM EFFECTIVENESS OF CBT IN TREATMENT OF COMORBID AUD/MDD ADOLESCENTS.
    Cornelius JR; Douaihy AB; Kirisci L; Daley DC
    Int J Med Biol Front; 2013; 19(2):. PubMed ID: 25339844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine in Comorbid Major Depression and Alcohol Use Disorder: A Long-Term Follow-Up Study.
    Cornelius JR; Douaihy AB; Clark DB; Daley DC; Chung TA; Wesesky MA; Wood DS; Salloum I
    J Addict Behav Ther Rehabil; 2013 Aug; 3(1):. PubMed ID: 25374892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain activity in adolescent major depressive disorder before and after fluoxetine treatment.
    Tao R; Calley CS; Hart J; Mayes TL; Nakonezny PA; Lu H; Kennard BD; Tamminga CA; Emslie GJ
    Am J Psychiatry; 2012 Apr; 169(4):381-8. PubMed ID: 22267183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficits in Access to Reward Are Associated with College Student Alcohol Use Disorder.
    Joyner KJ; Pickover AM; Soltis KE; Dennhardt AA; Martens MP; Murphy JG
    Alcohol Clin Exp Res; 2016 Dec; 40(12):2685-2691. PubMed ID: 27805267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Pilot SMART for Developing an Adaptive Treatment Strategy for Adolescent Depression.
    Gunlicks-Stoessel M; Mufson L; Westervelt A; Almirall D; Murphy S
    J Clin Child Adolesc Psychol; 2016; 45(4):480-94. PubMed ID: 25785788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pretreatment and posttreatment depressive symptoms on alcohol consumption following treatment in Project MATCH.
    Gamble SA; Conner KR; Talbot NL; Yu Q; Tu XM; Connors GJ
    J Stud Alcohol Drugs; 2010 Jan; 71(1):71-7. PubMed ID: 20105416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Comorbid Alcohol Use Disorder on Health-Related Quality of Life Among Patients With Depressive Symptoms.
    Luoto KE; Lindholm LH; Koivukangas A; Lassila A; Sintonen H; Leinonen E; Kampman O
    Front Psychiatry; 2021; 12():688136. PubMed ID: 34690824
    [No Abstract]   [Full Text] [Related]  

  • 39. A 3.5-year naturalistic follow-up study of depressed out-patients.
    Hoencamp E; Haffmans PM; Griens AM; Huijbrechts IP; Heycop ten Ham BF
    J Affect Disord; 2001 Oct; 66(2-3):267-71. PubMed ID: 11578681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression in patients with alcohol use disorders: Systematic review and meta-analysis of outcomes for independent and substance-induced disorders.
    Foulds JA; Adamson SJ; Boden JM; Williman JA; Mulder RT
    J Affect Disord; 2015 Oct; 185():47-59. PubMed ID: 26143404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.